Andrew Ekaputra

Corporate Officer/Principal chez Tissue Engineering & Generative Medicine International Societ

Profil

Andrew Krishna Ekaputra is currently working as a Principal (Healthcare Investments) at EDB Investments Pte Ltd.
and is also a Member at Tissue Engineering & Generative Medicine International Society.
Previously, he worked as a Technical Director at Cordlife Group Ltd.
Mr. Ekaputra completed his undergraduate and doctorate degrees from the National University of Singapore in 2003 and 2010 respectively.

Postes actifs de Andrew Ekaputra

Sociétés	Poste	Début
Tissue Engineering & Generative Medicine International Societ	Corporate Officer/Principal	-
EDB Investments Pte Ltd.	Private Equity Investor	01/07/2023

Anciens postes connus de Andrew Ekaputra

Sociétés	Poste	Fin
CORDLIFE GROUP LIMITED	Directeur Technique/Scientifique/R&D	-

Formation de Andrew Ekaputra

National University of Singapore

Doctorate Degree